[2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].

Abstract

The levels of 2'-5' oligoadenylate synthetase activity (2-5AS) were measured in the lymphocytes and sera of 32 patients with acute viral hepatitis and 20 patients with HBeAg positive chronic type B hepatitis, and the relationship between the effectiveness of interferon (IFN) therapy and 2-5AS reactivity was then studied. The lymphocyte 2-5AS (L.2-5AS) and the serum 2-5AS (S.2-5AS) levels in patients with any type of acute viral hepatitis at the acute stage were significantly higher than in the healthy subjects. The 2-5AS level in cases of acute type A viral hepatitis was significantly higher than in type B and type non A non B hepatitis. However, no significant difference in the 2-5AS levels between type B hepatitis and type non A non B hepatitis was observed. After recovery, the L.2-5AS and S.2-5AS levels decreased in patients with any type of acute viral hepatitis. No significant difference between the L.2-5AS level in healthy subjects and patients with chronic type B hepatitis was observed. The S.2-5AS level was significantly higher in patients with chronic type B hepatitis than in healthy subjects. During IFN administration, the L.2-5AS and S.2-5AS levels increased, with the maximum level and maximum rate of increase obtained on the 3rd day with respect to the L.2-5AS, and after one week with respect to the S.2-5AS. Of the 20 patients with chronic type B hepatitis with positive HBe antigen, 11 showed normalization of DNA-P, 4 disappearance of HBe antigen and 2 seroconversion of HBe antigen. In cases with a higher maximum rate of increase of the L.2-5AS, the effect of IFN therapy was observed to be greater.

• Authors: T Komiyama, M Akaike, K Satomura, H Okumura
• Journal: Nihon Ika Daigaku zasshi (Nihon Ika Daigaku Zasshi) Vol. 58 Issue 3 Pg. 262-72 (Jun 1991) ISSN: 0048-0444 [Print] Japan
• PMID: 1715348 (Publication Type: Journal Article)

Chemical References

• Hepatitis B e Antigens
• Interferons
• 2',5'-Oligoadenylate Synthetase

Topics

• 2',5'-Oligoadenylate Synthetase (metabolism)
• Acute Disease
• Adult
• Chronic Disease
• Female
• Hepatitis B (enzymology, therapy)
• Hepatitis B e Antigens (immunology)
• Hepatitis, Viral, Human (enzymology, therapy)
• Humans
• Interferons (therapeutic use)
• Lymphocytes (enzymology)
• Male